C12R 2001/045
Actinoplanes
C12R2001/045 (Actinoplanes) appears on 76 US grants and 7 published applications in this corpus.
Search patents in C12R- Granted patents
- 76
- Published applications
- 7
- Assignees
- 21
- Inventors
- 137
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 24 | 0 |
| 1982 | 10 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for the improved formation of acarbose8 Jul 2025US 12,351,847 B2
- Lantipeptide26 Nov 2019US 10,487,124 B2Fondazione Istituto Italiano Di Tecnologia
- Bacterial strain of Actinoplanes sp. and application thereof29 May 2018US 9,982,314 B2Zhejiang Hisun Pharmaceutical Co., Ltd.
- Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae18 Jun 2013US 8,465,947 B2Novacta Biosystems Limited
- Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. Liguriae2 Aug 2011US 7,989,416 B2Novacta Biosystems Limited
- Methods for the improved formation of acarbose20 Jul 2023US 2023/0227879 A1Bayer Aktiengesellschaft
- Bacterial strain of actinoplanes sp. and application thereof15 Sep 2016US 2016/0265071 A1Zhejiang Hisun Pharmaceutical Co., Ltd.
- Novel lantipeptide15 Oct 2015US 2015/0291670 A1Fondazione Istituto Italiano Di Tecnologia
- Lantibiotic NAI-802, Pharmaceutically Acceptable Salts, Compositions and Uses Thereof3 Apr 2014US 2014/0094402 A1Sentinella Pharmaceuticals, Inc.
- Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae15 Dec 2011US 2011/0306091 A1Novacta Biosystems Limited
Most cited
By later US patents
- Derivatives of A-30912A nucleus44US 4,293,489 AEli Lilly and Company · 1981
- Derivatives of A-21978C cyclic peptides36US 4,537,717 AEli Lilly and Company · 1985
- A-21978C cyclic peptides33US 4,524,135 AEli Lilly and Company · 1985
- A-30912A Nucleus31US 4,293,482 AEli Lilly and Company · 1981
- A-21978C cyclic peptides29US 4,482,487 AEli Lilly and Company · 1984